References analysis of the Wikipedia article "Thymidine kinase in clinical chemistry" in the English version

doi.org

Wintersberger E (1997). "Regulation and biological function of thymidine kinase". Biochem. Soc. Trans. 25 (1): 303–8. doi:10.1042/bst0250303. PMID 9056888.

Reichard P, Estborn B (1951). "Utilization of desoxyribosides in the synthesis of polynucleotides". J. Biol. Chem. 188 (2): 839–46. doi:10.1016/S0021-9258(19)77758-8. PMID 14824173.

Bessman MJ, Kornberg A, Lehman IR, Simms ES (1956). "Enzymic synthesis of deoxyribonucleic acid". Biochim. Biophys. Acta. 21 (1): 197–8. doi:10.1016/0006-3002(56)90127-5. PMID 13363894.

Bollum FJ, Potter VR (1958). "Incorporation of thymidine into deoxyribonucleic acid by enzymes from rat tissues". J. Biol. Chem. 233 (2): 478–82. doi:10.1016/S0021-9258(18)64787-8. PMID 13563524.

Weissman SM, Smellie RM, Paul J (1960). "Studies on the biosynthesis of deoxyribonucleic acid by extracts of mammalian cells. IV. The phosphorylation of thymidine". Biochim. Biophys. Acta. 45: 101–10. doi:10.1016/0006-3002(60)91430-x. PMID 13784139.

Gronowitz JS, Hagberg H, Källander CF, Simonsson B (1983). "The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma". Br. J. Cancer. 47 (4): 487–95. doi:10.1038/bjc.1983.78. PMC 2011337. PMID 6849793.

Blasco R, López-Otín C, Muñóz M, Bockamp EO, Simón-Mateo C, Viñuela E (1990). "Sequence and evolutionary relationships of African swine fever virus thymidine kinase". Virology. 178 (1): 301–4. doi:10.1016/0042-6822(90)90409-k. PMC 9534224. PMID 2389555.

Littlefield JW (1966). "The periodic synthesis of thymidine kinase in mouse fibroblasts". Biochim. Biophys. Acta. 114 (2): 398–403. doi:10.1016/0005-2787(66)90319-4. PMID 4223355.

Berk AJ, Clayton DA (1973). "A genetically distinct thymidine kinase in mammalian mitochondria. Exclusive labeling of mitochondrial deoxyribonucleic acid". J. Biol. Chem. 248 (8): 2722–9. doi:10.1016/S0021-9258(19)44066-0. PMID 4735344.

Berk AJ, Meyer BJ, Clayton DA (1973). "Mitochondrial-specific thymidine kinase". Arch. Biochem. Biophys. 154 (2): 563–5. doi:10.1016/0003-9861(73)90009-x. PMID 4632422.

Zhu C, Harlow LS, Berenstein D, Munch-Petersen S, Munch-Petersen B (2006). "Effect of C-terminal of human cytosolic thymidine kinase (TK1) on in vitro stability and enzymatic properties". Nucleosides Nucleotides Nucleic Acids. 25 (9–11): 1185–8. doi:10.1080/15257770600894436. PMID 17065087. S2CID 26971963.

Kit S, Dubbs DR (1963). "Acquisition of thymidine kinase activity by herpes simplex-infected mouse fibroblast cells". Biochem. Biophys. Res. Commun. 11: 55–9. doi:10.1016/0006-291x(63)90027-5. PMID 14033128.

McKnight SL (1980). "The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene". Nucleic Acids Res. 8 (24): 5949–64. doi:10.1093/nar/8.24.5949. PMC 328064. PMID 6258156.

Halliburton IW, Morse LS, Roizman B, Quinn KE (1980). "Mapping of the thymidine kinase genes of type 1 and type 2 herpes simplex viruses using intertypic recombinants". J. Gen. Virol. 49 (2): 235–53. doi:10.1099/0022-1317-49-2-235. PMID 6255066. S2CID 13276721.

McDougall JK, Masse TH, Galloway DA (1980). "Location and cloning of the herpes simplex virus type 2 thymidine kinase gene". J. Virol. 33 (3): 1221–4. doi:10.1128/JVI.33.3.1221-1224.1980. PMC 288658. PMID 6245273.

Kit S, Kit M, Qavi H, Trkula D, Otsuka H (1983). "Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene". Biochim. Biophys. Acta. 741 (2): 158–70. doi:10.1016/0167-4781(83)90056-8. PMID 6317035.

Sawyer MH, Ostrove JM, Felser JM, Straus SE (1986). "Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript". Virology. 149 (1): 1–9. doi:10.1016/0042-6822(86)90081-4. PMID 3004022.

Littler E, Zeuthen J, McBride AA, Trøst Sørensen E, Powell KL, Walsh-Arrand JE, Arrand JR (1986). "Identification of an Epstein-Barr virus-coded thymidine kinase". EMBO J. 5 (8): 1959–66. doi:10.1002/j.1460-2075.1986.tb04450.x. PMC 1167064. PMID 3019675.

Schlosser CA, Steglich C, deWet JR, Scheffler IE (1981). "Cell cycle-dependent regulation of thymidine kinase activity introduced into mouse LMTK- cells by DNA and chromatin-mediated gene transfer". Proc. Natl. Acad. Sci. U.S.A. 78 (2): 1119–23. Bibcode:1981PNAS...78.1119S. doi:10.1073/pnas.78.2.1119. PMC 319958. PMID 6940130.

Coppock DL, Pardee AB (1987). "Control of thymidine kinase mRNA during the cell cycle". Mol. Cell. Biol. 7 (8): 2925–32. doi:10.1128/MCB.7.8.2925. PMC 367911. PMID 3670299.

Stewart CJ, Ito M, Conrad SE (1987). "Evidence for transcriptional and post-transcriptional control of the cellular thymidine kinase gene". Mol. Cell. Biol. 7 (3): 1156–63. doi:10.1128/MCB.7.3.1156. PMC 365188. PMID 3561412.

Piper AA, Tattersall MH, Fox RM (1980). "The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriation". Biochim. Biophys. Acta. 633 (3): 400–9. doi:10.1016/0304-4165(80)90198-1. PMID 6260157.

Sherley JL, Kelly TJ (1988). "Regulation of human thymidine kinase during the cell cycle". J. Biol. Chem. 263 (17): 8350–8. doi:10.1016/S0021-9258(18)68484-4. PMID 3372530.

Gross MK, Kainz MS, Merrill GF (1987). "The chicken thymidine kinase gene is transcriptionally repressed during terminal differentiation: the associated decline in TK mRNA cannot account fully for the disappearance of TK enzyme activity". Dev. Biol. 122 (2): 439–51. doi:10.1016/0012-1606(87)90308-3. PMID 3596017.

Kauffman MG, Kelly TJ (1991). "Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis". Mol. Cell. Biol. 11 (5): 2538–46. doi:10.1128/MCB.11.5.2538. PMC 360023. PMID 1708095.

Sutterluety H, Bartl S, Karlseder J, Wintersberger E, Seiser C (1996). "Carboxy-terminal residues of mouse thymidine kinase are essential for rapid degradation in quiescent cells". J. Mol. Biol. 259 (3): 383–92. doi:10.1006/jmbi.1996.0327. PMID 8676376.

Welin M, Kosinska U, Mikkelsen NE, Carnrot C, Zhu C, Wang L, Eriksson S, Munch-Petersen B, Eklund H (2004). "Structures of thymidine kinase 1 of human and mycoplasmic origin". Proc. Natl. Acad. Sci. U.S.A. 101 (52): 17970–5. Bibcode:2004PNAS..10117970W. doi:10.1073/pnas.0406332102. PMC 539776. PMID 15611477.

Karlström AR, Neumüller M, Gronowitz JS, Källander CF (1990). "Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA". Mol. Cell. Biochem. 92 (1): 23–35. doi:10.1007/BF00220716. PMID 2155379. S2CID 21351513.

Gronowitz JS, Källander CF (1980). "Optimized assay for thymidine kinase and its application to the detection of antibodies against herpes simplex virus type 1- and 2-induced thymidine kinase". Infection and Immunity. 29 (2): 425–34. doi:10.1128/iai.29.2.425-434.1980. PMC 551136. PMID 6260651.

Gronowitz JS, Källander FR, Diderholm H, Hagberg H, Pettersson U (1984). "Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans". International Journal of Cancer. 33 (1): 5–12. doi:10.1002/ijc.2910330103. PMID 6693195. S2CID 43720702.

Gronowitz JS, Källander CF (1983). "A sensitive assay for detection of deoxythymidine kinase and its application to herpesvirus diagnosis". Current Topics in Microbiology and Immunology. 104: 235–45. doi:10.1007/978-3-642-68949-9_14. ISBN 978-3-642-68951-2. PMID 6307593.

von Euler HP, Öhrvik AB, Eriksson SK (2006). "A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs". Research in Veterinary Science. 80 (1): 17–24. doi:10.1016/j.rvsc.2005.05.001. PMID 16140350.

Öhrvik A, Lindh M, Einarsson R, Grassi J, Eriksson S (2004). "Sensitive nonradiometric method for determining thymidine kinase 1 activity". Clinical Chemistry. 50 (9): 1597–606. doi:10.1373/clinchem.2003.030379. PMID 15247154.

Nisman B, Allweis T, Kadouri L, Mali B, Hamburger T, Baras M, Gronowitz S, Peretz T (2013). "Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients". Clin. Chem. Lab. Med. 51 (2): 439–47. doi:10.1515/cclm-2012-0162. PMID 23093267. S2CID 7615993.

Bacovsky J, Myslivecek M, Minarik J, Scudla V, Pika T, Zapletalova J, Petrova P, Bartkova M, Adam T, Gronowitz SJ (2015). "Analysis of thymidine kinase serum levels by novel method DiviTum in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT". Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia. 159 (1): 135–8. doi:10.5507/bp.2014.008. PMID 24572488.

Stålhandske P, Wang L, Westberg S, von Euler H, Groth E, Gustafsson SA, Eriksson S, Lennerstrand J (2013). "Homogeneous assay for real-time and simultaneous detection of thymidine kinase 1 and deoxycytidine kinase activities". Anal. Biochem. 432 (2): 155–64. doi:10.1016/j.ab.2012.08.004. PMID 22902741.

Jagarlamudi, KK; Hansson, LO; Eriksson, S (18 February 2015). "Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker". BMC Cancer. 15: 66. doi:10.1186/s12885-015-1073-8. PMC 4336758. PMID 25881026.

Jagarlamudi KK, Hansson LO, Eriksson S (2015). "Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker". BMC Cancer. 15: 66. doi:10.1186/s12885-015-1073-8. PMC 4336758. PMID 25881026.

Kumar, JK; Aronsson, AC; Pilko, G; Zupan, M; Kumer, K; Fabjan, T; Osredkar, J; Eriksson, S (September 2016). "A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease". Tumour Biology. 37 (9): 11937–11945. doi:10.1007/s13277-016-5024-z. PMC 5080325. PMID 27079872.

He Q, Zou L, Zhang PA, Lui JX, Skog S, Fornander T (2000). "The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody". The International Journal of Biological Markers. 15 (2): 139–46. doi:10.1177/172460080001500203. PMID 10883887. S2CID 25940455.

Pagaduan JV, Ramsden M, O'Neill K, Woolley AT (2015). "Microchip immunoaffinity electrophoresis of antibody-thymidine kinase 1 complex". Electrophoresis. 36 (5): 813–7. doi:10.1002/elps.201400436. PMC 4346389. PMID 25486911.

Hagberg H, Glimelius B, Gronowitz S, Killander A, Källander C, Schröder T (1984). "Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis". Scand J Haematol. 33 (1): 59–67. doi:10.1111/j.1600-0609.1984.tb02211.x. PMID 6379852.

Hallek M, Wanders L, Strohmeyer S, Emmerich B (1992). "Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications". Ann. Hematol. 65 (1): 1–5. doi:10.1007/bf01715117. PMID 1643153. S2CID 2748430.

Rehn S, Gronowitz JS, Källander C, Sundström C, Glimelius B (1995). "Deoxythymidine kinase in the tumor cells and serum of patients with non-Hodgkin lymphomas". Br. J. Cancer. 71 (5): 1099–105. doi:10.1038/bjc.1995.213. PMC 2033808. PMID 7734308.

Suki S, Swan F, Tucker S, Fritsche HA, Redman JR, Rodriguez MA, McLaughlin P, Romaguera J, Hagemeister FB, Velasquez WS (1995). "Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase". Leukemia & Lymphoma. 18 (1–2): 87–92. doi:10.3109/10428199509064927. PMID 8580834.

Suzuki K, Terui Y, Nakano K, Nara E, Nasu K, Ueda K, Nishimura N, Mishima Y, Sakajiri S, Yokoyama M, Takahashi S, Hatake K (2012). "High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone". Leukemia & Lymphoma. 53 (5): 849–54. doi:10.3109/10428194.2011.635858. PMID 22035416. S2CID 34860902.

Procházka V, Faber E, Raida L, Langová K, Indrák K, Papajík T (2012). "High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma". Leukemia & Lymphoma. 53 (7): 1306–10. doi:10.3109/10428194.2011.654339. PMID 22263569. S2CID 5461889.

Suzuki K, Terui Y, Yokoyama M, Ueda K, Nishimura N, Mishima Y, Sakajiri S, Tsuyama N, Takeuchi K, Hatake K (2013). "Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone". Leukemia & Lymphoma. 54 (11): 2412–7. doi:10.3109/10428194.2013.779690. PMID 23488601. S2CID 207510234.

Tsuji T, Satoh K, Nakano H, Nishide Y, Uemura Y, Tanaka S, Kogo M (2015). "Predictors of the necessity for lymph node biopsy of cervical lymphadenopathy". J Craniomaxillofac Surg. 43 (10): 2200–4. doi:10.1016/j.jcms.2015.09.010. PMID 26545929.

Källander CF, Simonsson B, Hagberg H, Gronowitz JS (1984). "Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia". Cancer. 54 (11): 2450–5. doi:10.1002/1097-0142(19841201)54:11<2450::aid-cncr2820541123>3.0.co;2-r. PMID 6498737.

Källander CF, Simonsson B, Gronowitz JS, Nilsson K (1987). "Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia". Eur. J. Haematol. 38 (4): 331–7. doi:10.1111/j.1600-0609.1987.tb00007.x. PMID 3609253. S2CID 7752345.

Hallek M, Wanders L, Ostwald M, Busch R, Senekowitsch R, Stern S, Schick HD, Kuhn-Hallek I, Emmerich B (1996). "Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma". Leukemia & Lymphoma. 22 (5–6): 439–47. doi:10.3109/10428199609054782. PMID 8882957.

Bazargan A, Tam CS, Keating MJ (2012). "Predicting survival in chronic lymphocytic leukemia". Expert Review of Anticancer Therapy. 12 (3): 393–403. doi:10.1586/era.12.2. PMID 22369330. S2CID 43563863.

Pflug N, Bahlo J, Shanafelt TD, Eichhorst BF, Bergmann MA, Elter T, Bauer K, Malchau G, Rabe KG, Stilgenbauer S, Döhner H, Jäger U, Eckart MJ, Hopfinger G, Busch R, Fink AM, Wendtner CM, Fischer K, Kay NE, Hallek M (2014). "Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia". Blood. 124 (1): 49–62. doi:10.1182/blood-2014-02-556399. PMC 4260976. PMID 24797299.

Hagag AA, Saad MA, Mohamed SA (2015). "Clinical significance of thymidine kinase in Egyptian children with acute lymphoblastic leukemia". South Asian Journal of Cancer. 4 (2): 72–4. doi:10.4103/2278-330X.155675. PMC 4418086. PMID 25992345.

López-Martínez B, Vilchis Ordoñez A, Salazar Garcia M, Klünder-Klünder M, Parra-Ortega I, Dorantes-Acosta E, Angeles-Floriano T (2015). "Thymidine Kinase: A Biomarker for Recently Diagnosed Acute Leukemia in Pediatric Patients According to the Cell Line Involved". Arch. Med. Res. 46 (8): 630–4. doi:10.1016/j.arcmed.2015.11.005. PMID 26656666.

Simonsson B, Källander CF, Brenning G, Killander A, Ahre A, Gronowitz JS (1985). "Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma". British Journal of Haematology. 61 (2): 215–24. doi:10.1111/j.1365-2141.1985.tb02820.x. PMID 4041368. S2CID 46123711.

Simonsson B, Källander CF, Brenning G, Killander A, Gronowitz JS, Bergström R (1988). "Biochemical markers in multiple myeloma: a multivariate analysis". British Journal of Haematology. 69 (1): 47–53. doi:10.1111/j.1365-2141.1988.tb07601.x. PMID 3289607. S2CID 9103043.

Musto P, Bodenizza C, Falcone A, D'Arena G, Scalzulli P, Perla G, Modoni S, Parlatore L, Valvano MR, Carotenuto M (1995). "Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemia". British Journal of Haematology. 90 (1): 125–30. doi:10.1111/j.1365-2141.1995.tb03390.x. PMID 7786774. S2CID 43707840.

Aul C, Germing U, Gattermann N, Söhngen D, Heyll A (1996). "[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome]". Deutsche Medizinische Wochenschrift (in German). 121 (37): 1113–8. doi:10.1055/s-2008-1043114. PMID 8925725.

Gronowitz JS, Steinholtz L, Källander CF, Hagberg H, Bergh J (1986). "Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers". Cancer. 58 (1): 111–8. doi:10.1002/1097-0142(19860701)58:1<111::aid-cncr2820580120>3.0.co;2-k. PMID 3011236.

Gronowitz JS, Bergström R, Nôu E, Påhlman S, Brodin O, Nilsson S, Källander CF (1990). "Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis". Cancer. 66 (4): 722–32. doi:10.1002/1097-0142(19900815)66:4<722::aid-cncr2820660421>3.0.co;2-j. PMID 2167141.

Korkmaz T, Seber S, Okutur K, Basaran G, Yumuk F, Dane F, Ones T, Polat O, Madenci OC, Demir G, Turhal NS (2013). "Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer". Biomarkers. 18 (1): 88–94. doi:10.3109/1354750X.2012.738250. PMID 23116493. S2CID 22781348.

Nisman B, Nechushtan H, Biran H, Gantz-Sorotsky H, Peled N, Gronowitz S, Peretz T (2014). "Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief report". Journal of Thoracic Oncology. 9 (10): 1568–72. doi:10.1097/JTO.0000000000000276. PMID 25521401. S2CID 205734677.

Jiang, ZF; Wang, M; Xu, JL (1 February 2018). "Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer". Life Sciences. 194: 1–6. doi:10.1016/j.lfs.2017.12.020. PMID 29247745. S2CID 46859323.

Lou, X; Zhou, J; Ma, H; Xu, S; He, E; Skog, S; Wang, H (August 2017). "The Half-Life of Serum Thymidine Kinase 1 Concentration Is an Important Tool for Monitoring Surgical Response in Patients with Lung Cancer: A Meta-Analysis". Genetic Testing and Molecular Biomarkers. 21 (8): 471–478. doi:10.1089/gtmb.2017.0003. PMID 28817340.

Chen F, Tang L, Xia T, He E, Hu G, Li Y, Zhang M, Zhou J, Eriksson S, Skog S (2013). "Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer". Molecular and Clinical Oncology. 1 (5): 894–902. doi:10.3892/mco.2013.149. PMC 3915673. PMID 24649267.

Nisman B, Allweis T, Kaduri L, Maly B, Gronowitz S, Hamburger T, Peretz T (2010). "Serum thymidine kinase 1 activity in breast cancer". Cancer Biomarkers. 7 (2): 65–72. doi:10.3233/CBM-2010-0148. PMID 21178264.

Huang ZH, Tian XS, Li R, Wang XM, Wen W, Guan H, Yang YJ (2012). "Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer". Experimental and Therapeutic Medicine. 3 (2): 331–335. doi:10.3892/etm.2011.395. PMC 3438657. PMID 22969891.

Nisman B, Kadouri L, Allweis T, Maly B, Hamburger T, Gronowitz S, Peretz T (2013). "Increased proliferative background in healthy women with BRCA1/2 haploinsufficiency is associated with high risk for breast cancer". Cancer Epidemiol. Biomarkers Prev. 22 (11): 2110–5. doi:10.1158/1055-9965.EPI-13-0193. PMID 23966579. S2CID 30440892.

Bjöhle J, Bergqvist J, Gronowitz JS, Johansson H, Carlsson L, Einbeigi Z, Linderholm B, Loman N, Malmberg M, Söderberg M, Sundquist M, Walz TM, Fernö M, Bergh J, Hatschek T (2013). "Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial". Breast Cancer Research and Treatment. 139 (3): 751–8. doi:10.1007/s10549-013-2579-x. PMID 23736998. S2CID 21045901.

Bolayirli M, Papila C, Korkmaz GG, Papila B, Aydoğan F, Karataş A, Uzun H (2013). "Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy". Journal of Clinical Laboratory Analysis. 27 (3): 220–6. doi:10.1002/jcla.21587. PMC 6807516. PMID 23686779.

Lewenhaupt A, Ekman P, Eneroth P, Nilsson B (1990). "Tumour markers as prognostic aids in prostatic carcinoma". British Journal of Urology. 66 (2): 182–7. doi:10.1111/j.1464-410x.1990.tb14900.x. PMID 1697204.

Ekman P, Lewenhaupt A (1991). "Serum tumour markers in human prostatic carcinoma. The value of a marker panel for prognostic information". Acta Oncol. 30 (2): 173–5. doi:10.3109/02841869109092345. PMID 2029401.

Letocha H, Eklöv S, Gronowitz S, Norlén BJ, Nilsson S (1996). "Deoxythymidine kinase in the staging of prostatic adenocarcinoma". The Prostate. 29 (1): 15–9. doi:10.1002/(SICI)1097-0045(199607)29:1<15::AID-PROS2>3.0.CO;2-H. PMID 8685050.

Nisman B, Yutkin V, Nechushtan H, Gofrit ON, Peretz T, Gronowitz S, Pode D (2010). "Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy". Urology. 76 (2): 513.e1–6. doi:10.1016/j.urology.2010.04.034. PMID 20573390.

Rausch S, Hennenlotter J, Teepe K, Kuehs U, Aufderklamm S, Bier S, Mischinger J, Gakis G, Stenzl A, Schwentner C, Todenhöfer T (2015). "Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1". Urologic Oncology. 33 (10): 426.e21–9. doi:10.1016/j.urolonc.2015.06.007. PMID 26231311.

Liu, Y; Ling, Y; Qi, Q; Tang, Y; Xu, J; Tong, Z; Sheng, G; Yang, Q; Pan, Y (November 2011). "Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer". Experimental and Therapeutic Medicine. 2 (6): 1177–1181. doi:10.3892/etm.2011.338. PMC 3440839. PMID 22977640.

Liu Y, Ling Y, Qi Q, Tang Y, Xu J, Tong Z, Sheng G, Yang Q, Pan Y (2011). "Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer". Experimental and Therapeutic Medicine. 2 (6): 1177–1181. doi:10.3892/etm.2011.338. PMC 3440839. PMID 22977640.

Zhang SY, Lin BD, Li BR (2015). "Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma". FEBS Open Bio. 5: 240–4. doi:10.1016/j.fob.2015.03.010. PMC 4392066. PMID 25870783.

Kolberg M, Høland M, Lind GE, Ågesen TH, Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B, Lothe RA (2015). "Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection". Molecular Oncology. 9 (6): 1129–39. doi:10.1016/j.molonc.2015.02.005. PMC 5528761. PMID 25769404.

Wu BJ, Li WP, Qian C, Ding W, Zhou ZW, Jiang H (2013). "Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma". Tumour Biology. 34 (2): 643–8. doi:10.1007/s13277-012-0591-0. PMID 23179401. S2CID 3207986.

Wang, Y; Jiang, X; Dong, S; Shen, J; Yu, H; Zhou, J; Li, J; Ma, H; He, E; Skog, S (11 March 2016). "Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people". Cancer Biomarkers. 16 (4): 529–36. doi:10.3233/CBM-160594. PMID 27002755.

Ellims PH, Hayman RJ, Van der Weyden MB (1979). "Expression of fetal thymidine kinase in human cobalamin or folate deficient lymphocytes". Biochemical and Biophysical Research Communications. 89 (1): 103–7. doi:10.1016/0006-291x(79)90949-5. PMID 475797.

Neumüller M, Källander CF, Gronowitz JS (1989). "Detection and characteristics of DNA polymerase activity in serum from patients with malignant, viral, or B12-deficiency disease". Enzyme. 41 (1): 6–16. doi:10.1159/000469045. PMID 2543552.

Källander CF, Gronowitz JS, Olding-Stenkvist E (1983). "Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid". Journal of Clinical Microbiology. 17 (2): 280–7. doi:10.1128/JCM.17.2.280-287.1983. PMC 272623. PMID 6339548.

Larsdotter S, Nostell K, von Euler H (2015). "Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma". Veterinary Journal. 205 (2): 313–6. doi:10.1016/j.tvjl.2015.01.019. PMID 25744802.

von Euler H, Einarsson R, Olsson U, Lagerstedt AS, Eriksson S (2004). "Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease". Journal of Veterinary Internal Medicine. 18 (5): 696–702. doi:10.1111/j.1939-1676.2004.tb02608.x. PMID 15515587.

Jagarlamudi KK, Westberg S, Rönnberg H, Eriksson S (2014). "Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker". BMC Veterinary Research. 10: 228. doi:10.1186/s12917-014-0228-1. PMC 4195903. PMID 25293656.

Selting KA, Sharp CR, Ringold R, Knouse J (2015). "Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease". Veterinary and Comparative Oncology. 13 (4): 373–84. doi:10.1111/vco.12052. PMID 23859156.

Elliott JW, Cripps P, Blackwood L (2013). "Thymidine kinase assay in canine lymphoma". Veterinary and Comparative Oncology. 11 (1): 1–13. doi:10.1111/j.1476-5829.2011.00296.x. PMID 22236202.

Jagarlamudi KK, Moreau L, Westberg S, Rönnberg H, Eriksson S (2015). "A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management". PLOS ONE. 10 (9): e0137871. Bibcode:2015PLoSO..1037871J. doi:10.1371/journal.pone.0137871. PMC 4569288. PMID 26366881.

Taylor SS, Dodkin S, Papasouliotis K, Evans H, Graham PA, Belshaw Z, Westberg S, von Euler HP (2013). "Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma". Journal of Feline Medicine and Surgery. 15 (2): 142–7. doi:10.1177/1098612X12463928. PMC 10816663. PMID 23076596. S2CID 9465188.

Tawfeeq MM, Miura S, Horiuchi N, Kobayashi Y, Furuoka H, Inokuma H (2013). "Utility of serum thymidine kinase activity measurements for cases of bovine leukosis with difficult clinical diagnoses". The Journal of Veterinary Medical Science. 75 (9): 1167–72. doi:10.1292/jvms.12-0572. PMID 23628971.

Sharif H, Hagman R, Wang L, Eriksson S (2013). "Elevation of serum thymidine kinase 1 in a bacterial infection: canine pyometra". Theriogenology. 79 (1): 17–23. doi:10.1016/j.theriogenology.2012.09.002. PMID 23102844.

Arnér ES, Spasokoukotskaja T, Eriksson S (1992). "Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues". Biochemical and Biophysical Research Communications. 188 (2): 712–8. doi:10.1016/0006-291x(92)91114-6. PMID 1359886.

Romain S, Spyratos F, Guirou O, Deytieux S, Chinot O, Martin PM (1994). "Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group Report". European Journal of Cancer. 30A (14): 2163–5. doi:10.1016/0959-8049(94)00376-g. PMID 7857717.

Alegre MM, Robison RA, O'Neill KL (2012). "Thymidine kinase 1 upregulation is an early event in breast tumor formation". J Oncol. 2012: 1–5. doi:10.1155/2012/575647. PMC 3388419. PMID 22778736.

Machovich R, Greengard O (1972). "Thymidine kinase in rat tissues during growth and differentiation". Biochimica et Biophysica Acta (BBA) - General Subjects. 286 (2): 375–81. doi:10.1016/0304-4165(72)90273-5. PMID 4660462.

Herzfeld A, Greengard O (1980). "Enzyme activities in human fetal and neoplastic tissues". Cancer. 46 (9): 2047–54. doi:10.1002/1097-0142(19801101)46:9<2047::aid-cncr2820460924>3.0.co;2-q. PMID 6253048.

Herzfeld A, Raper SM, Gore I (1980). "The ontogeny of thymidine kinase in tissues of man and rat". Pediatric Research. 14 (12): 1304–10. doi:10.1203/00006450-198012000-00006. PMID 7208144. S2CID 30647108.

Wang L, Eriksson S (2008). "5-Bromovinyl 2'-deoxyuridine phosphorylation by mitochondrial and cytosolic thymidine kinase (TK2 and TK1) and its use in selective measurement of TK2 activity in crude extracts". Nucleosides, Nucleotides & Nucleic Acids. 27 (6): 858–62. doi:10.1080/15257770802146510. PMID 18600552. S2CID 3134631.

Schollenberger S, Taureck D, Wilmanns W (1972). "[Enzymes of thymidine and thymidylate metabolism in normal and pathological blood and bone marrow cells]". Blut (in German). 25 (5): 318–34. doi:10.1007/BF01631814. PMID 4508724.

Nakao K, Fujioka S (1968). "Thymidine kinase activity in the human bone marrow from various blood diseases". Life Sciences. 7 (8): 395–9. doi:10.1016/0024-3205(68)90039-8. PMID 5649653.

Wickramasinghe SN, Olsen I, Saunders JE (1975). "Thymidine kinase activity in human bone marrow cells". Scandinavian Journal of Haematology. 15 (2): 139–44. doi:10.1111/j.1600-0609.1975.tb01065.x. PMID 1059244.

Stafford MA, Jones OW (1972). "The presence of "fetal" thymidine kinase in human tumors". Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 277 (2): 439–42. doi:10.1016/0005-2787(72)90423-6. PMID 4672678.

Persson L, Gronowitz SJ, Källander CF (1986). "Thymidine kinase in extracts of human brain tumours". Acta Neurochirurgica. 80 (3–4): 123–7. doi:10.1007/bf01812286. PMID 3012969. S2CID 3115996.

Lipkin M, Deschner E, Troncale F (1970). "Cell differentiation and the development of colonic neoplasms". CA: A Cancer Journal for Clinicians. 20 (6): 386–90. doi:10.3322/canjclin.20.6.386. PMID 4992499. S2CID 37440652.

Lipkin M (1971). "Proliferation and differentiation of normal and neoplastic cells in the colon of man". Cancer. 28 (1): 38–40. doi:10.1002/1097-0142(197107)28:1<38::aid-cncr2820280108>3.0.co;2-w. PMID 5110642.

Weber G, Lui MS, Takeda E, Denton JE (1980). "Enzymology of human colon tumors". Life Sciences. 27 (9): 793–9. doi:10.1016/0024-3205(80)90333-1. PMID 7412505.

Sakamoto S, Sagara T, Iwama T, Kawasaki T, Okamoto R (1985). "Increased activities of thymidine kinase isozymes in human colon polyp and carcinoma". Carcinogenesis. 6 (6): 917–9. doi:10.1093/carcin/6.6.917. PMID 4006080.

Sakamoto S, Okamoto R (1992). "Thymidine kinase activity in familial adenomatous polyposis". The Tohoku Journal of Experimental Medicine. 168 (2): 291–301. doi:10.1620/tjem.168.291. PMID 1339104.

Sakamoto S, Iwama T, Ebuchi M, Tsukada K, Sagara T, Kawasaki T, Murakami S, Kasahara N, Kudo H, Okamoto R (1986). "Increased activities of thymidine kinase isozymes in human mammary tumours". The British Journal of Surgery. 73 (4): 272–3. doi:10.1002/bjs.1800730409. PMID 3697655. S2CID 30953996.

O'Neill KL, Hoper M, Odling-Smee GW (1992). "Can thymidine kinase levels in breast tumors predict disease recurrence?". Journal of the National Cancer Institute. 84 (23): 1825–8. doi:10.1093/jnci/84.23.1825. PMID 1433372.

Romain S, Chinot O, Guirou O, Soullière M, Martin PM (1994). "Biological heterogeneity of ER-positive breast cancers in the post-menopausal population". International Journal of Cancer. 59 (1): 17–9. doi:10.1002/ijc.2910590105. PMID 7927897. S2CID 24941624.

Greengard O, Head JF, Goldberg SL, Kirschner PA (1982). "Enzyme pathology and the histologic categorization of human lung tumors: the continuum of quantitative biochemical indices of neoplasticity". Cancer. 49 (3): 460–7. doi:10.1002/1097-0142(19820201)49:3<460::aid-cncr2820490312>3.0.co;2-y. PMID 6277448.

Greengard O, Head JF, Goldberg SL, Kirschner PA (1985). "Biochemical measure of the volume doubling time of human pulmonary neoplasms". Cancer. 55 (7): 1530–5. doi:10.1002/1097-0142(19850401)55:7<1530::aid-cncr2820550720>3.0.co;2-v. PMID 2983858.

Konishi T, Miyama T, Sakamoto S, Hirata T, Mafune K, Hiraishi M, Idezuki Y (1992). "Activities of thymidylate synthetase and thymidine kinase in gastric cancer". Surgical Oncology. 1 (3): 215–21. doi:10.1016/0960-7404(92)90067-u. PMID 1341254.

Greengard O, Head JF, Chahinian AP, Goldberg SL (1987). "Enzyme pathology of human mesotheliomas". Journal of the National Cancer Institute. 78 (4): 617–22. doi:10.1093/jnci/78.4.617. PMID 2882044.

Borovanský J, Stríbrná J, Elleder M, Netíková I (1994). "Thymidine kinase in malignant melanoma". Melanoma Research. 4 (5): 275–9. doi:10.1097/00008390-199410000-00001. PMID 7858409. S2CID 28749344.

Sakamoto S, Murakami S, Sugawara M, Mishima Y, Okamoto R (1991). "Increased activities of thymidylate synthetase and thymidine kinase in human thyroid tumors". Thyroid. 1 (4): 347–51. doi:10.1089/thy.1991.1.347. PMID 1841732.

Wilms K, Wilmanns W (1972). "[Effects of dauno-rubidomycin and adriamycin on enzymes of DNA synthesis in leukocytes in vivo and in culture]". Klinische Wochenschrift (in German). 50 (18): 866–70. doi:10.1007/bf01488943. PMID 4507472. S2CID 25051929.

Zhang HJ, Kennedy BJ, Kiang DT (1984). "Thymidine kinase as a predictor of response to chemotherapy in advanced breast cancer". Breast Cancer Research and Treatment. 4 (3): 221–5. doi:10.1007/bf01806488. PMID 6487823. S2CID 36083198.

Björklund B (1978). "Tissue polypeptide antigen (TPA): Biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook". Laboratory Testing for Cancer. Antibiotics and Chemotherapy. Vol. 22. pp. 16–31. doi:10.1159/000401148. ISBN 978-3-8055-2765-1. PMID 623439.

Vickers AJ, Eastham JA, Scardino PT, Lilja H (2016). "The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening". Urology. 91: 12–8. doi:10.1016/j.urology.2015.12.054. PMC 4842100. PMID 26850815.

Xiang Y, Zeng H, Liu X, Zhou H, Luo L, Duan C, Luo X, Yan H (2013). "Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis". Biomedical Reports. 1 (4): 629–637. doi:10.3892/br.2013.114. PMC 3916991. PMID 24648999.

Cao X, Wang Y, Yang P, Zhou H, Liu C, Chen Z (2014). "[Application of serum thymidine kinase 1 of 26 055 cases in health screening for early detection of premalignant/early malignant tumors]". Zhong Nan da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences (in Chinese). 39 (10): 1029–34. doi:10.11817/j.issn.1672-7347.2014.10.007. PMID 25355255.

Asghar U, Witkiewicz AK, Turner NC, Knudsen ES (2015). "The history and future of targeting cyclin-dependent kinases in cancer therapy". Nat Rev Drug Discov. 14 (2): 130–46. doi:10.1038/nrd4504. PMC 4480421. PMID 25633797.

espacenet.com

worldwide.espacenet.com

WO application 2006000246, Gronowitz JS, "A method and kit for determination of thymidine kinase activity and use thereof", published 2006-02-24, assigned to Gronowitz JS

nih.gov

pubmed.ncbi.nlm.nih.gov

Kit S (1985). "Thymidine kinase". Microbiol. Sci. 2 (12): 369–75. PMID 3939993.

Wintersberger E (1997). "Regulation and biological function of thymidine kinase". Biochem. Soc. Trans. 25 (1): 303–8. doi:10.1042/bst0250303. PMID 9056888.

Reichard P, Estborn B (1951). "Utilization of desoxyribosides in the synthesis of polynucleotides". J. Biol. Chem. 188 (2): 839–46. doi:10.1016/S0021-9258(19)77758-8. PMID 14824173.

Bessman MJ, Kornberg A, Lehman IR, Simms ES (1956). "Enzymic synthesis of deoxyribonucleic acid". Biochim. Biophys. Acta. 21 (1): 197–8. doi:10.1016/0006-3002(56)90127-5. PMID 13363894.

Littlefield JW (1966). "The periodic synthesis of thymidine kinase in mouse fibroblasts". Biochim. Biophys. Acta. 114 (2): 398–403. doi:10.1016/0005-2787(66)90319-4. PMID 4223355.

Berk AJ, Meyer BJ, Clayton DA (1973). "Mitochondrial-specific thymidine kinase". Arch. Biochem. Biophys. 154 (2): 563–5. doi:10.1016/0003-9861(73)90009-x. PMID 4632422.

Coppock DL, Pardee AB (1987). "Control of thymidine kinase mRNA during the cell cycle". Mol. Cell. Biol. 7 (8): 2925–32. doi:10.1128/MCB.7.8.2925. PMC 367911. PMID 3670299.

Pelka-Fleischer R, Ruppelt W, Wilmanns W, Sauer H, Schalhorn A (1987). "Relation between cell cycle stage and the activity of DNA-synthesizing enzymes in cultured human lymphoblasts: investigations on cell fractions enriched according to cell cycle stages by way of centrifugal elutriation". Leukemia. 1 (3): 182–7. PMID 3669741.

Sherley JL, Kelly TJ (1988). "Regulation of human thymidine kinase during the cell cycle". J. Biol. Chem. 263 (17): 8350–8. doi:10.1016/S0021-9258(18)68484-4. PMID 3372530.

Alegre, MM; Weyant, MJ; Bennett, DT; Yu, JA; Ramsden, MK; Elnaggar, A; Robison, RA; O'Neill, KL (May 2014). "Serum detection of thymidine kinase 1 as a means of early detection of lung cancer". Anticancer Research. 34 (5): 2145–51. PMID 24778016.

He, Q; Zhang, P; Zou, L; Li, H; Wang, X; Zhou, S; Fornander, T; Skog, S (October 2005). "Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity". Oncology Reports. 14 (4): 1013–9. PMID 16142366.

He, Q; Skog, S; Wang, N; Eriksson, S; Tribukait, B (June 1996). "Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation". European Journal of Cell Biology. 70 (2): 117–24. PMID 8793383.

Doi S, Naito K, Yamada K (1990). "Serum deoxythymidine kinase as a progressive marker of hematological malignancy". Nagoya J Med Sci. 52 (1–4): 19–26. PMID 2381458.

Ellims PH, Van der Weyden MB, Medley G (1981). "Thymidine kinase isoenzymes in human malignant lymphoma". Cancer Res. 41 (2): 691–5. PMID 7448815.

Bogni A, Cortinois A, Grasselli G, Seregni E, Crippa F, Castellani MR, Bombardieri E (1994). "Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patients". J. Biol. Regul. Homeost. Agents. 8 (4): 121–5. PMID 7660854.

Gatt ME, Goldschmidt N, Kalichman I, Friedman M, Aronson AC, Barak V (2015). "Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation". Anticancer Research. 35 (5): 3019–26. PMID 25964590.

Rivkina A, Vitols G, Murovska M, Lejniece S (2011). "Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels". Experimental Oncology. 33 (2): 99–103. PMID 21716207.

Alegre MM, Weyant MJ, Bennett DT, Yu JA, Ramsden MK, Elnaggar A, Robison RA, O'Neill KL (2014). "Serum detection of thymidine kinase 1 as a means of early detection of lung cancer". Anticancer Research. 34 (5): 2145–51. PMID 24778016.

Larson A, Fritjofsson A, Norlén BJ, Gronowitz JS, Ronquist G (1985). "Prostate specific acid phosphatase versus five other possible tumor markers: a comparative study in men with prostatic carcinoma". Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum. 179: 81–8. PMID 2417306.

Ji Y, Wu XB, Chen JY, Hu B, Zhu QK, Zhu XF, Zheng MF (2015). "Serum thymidine kinase 1 levels correlate with clinical characteristics of esophageal squamous cell carcinoma". Int J Clin Exp Med. 8 (8): 12850–7. PMC 4612885. PMID 26550200.

Tufveson G, Tötterman TH, Källander CF, Hagström A, Gronowitz JS (1988). "Serum thymidine-kinase and cytomegalovirus-specific antibodies after renal transplantation". Transplantation Proceedings. 20 (3): 405–7. PMID 2837850.

Elliott JW, Cripps P, Blackwood L (2013). "Thymidine kinase assay in canine lymphoma". Veterinary and Comparative Oncology. 11 (1): 1–13. doi:10.1111/j.1476-5829.2011.00296.x. PMID 22236202.

Nakao K, Fujioka S (1968). "Thymidine kinase activity in the human bone marrow from various blood diseases". Life Sciences. 7 (8): 395–9. doi:10.1016/0024-3205(68)90039-8. PMID 5649653.

Gordon HL, Bardos TJ, Chmielewicz ZF, Ambrus JL (1968). "Comparative study of the thymidine kinase and thymidylate kinase activities and of the feedbach inhibition of thymidine kinase in normal and neoplastic human tissue". Cancer Research. 28 (10): 2068–77. PMID 5696936.

Maehara Y, Nakamura H, Nakane Y, Kawai K, Okamoto M, Nagayama S, Shirasaka T, Fujii S (1982). "Activities of various enzymes of pyrimidine nucleotide and DNA syntheses in normal and neoplastic human tissues". Gan. 73 (2): 289–98. PMID 6288502.

Persson L, Gronowitz SJ, Källander CF (1986). "Thymidine kinase in extracts of human brain tumours". Acta Neurochirurgica. 80 (3–4): 123–7. doi:10.1007/bf01812286. PMID 3012969. S2CID 3115996.

Filanovskaia LI, Togo AV, Shcherbakova EG, Blinov MN (1994). "[Thymidine kinase activity in leukocytes from patients with chronic myeloid leukemia at various periods in the disease]". Voprosy Meditsinskoi Khimii (in Russian). 40 (1): 29–32. PMID 8122406.

Weber G, Lui MS, Takeda E, Denton JE (1980). "Enzymology of human colon tumors". Life Sciences. 27 (9): 793–9. doi:10.1016/0024-3205(80)90333-1. PMID 7412505.

Sagara T, Tsukada K, Iwama T, Mishima Y, Sakamoto S, Okamoto R (1985). "[Thymidine kinase isozymes in human colon polyps]". Nihon Gan Chiryo Gakkai Shi (in Japanese). 20 (7): 1312–6. PMID 4078430.

Galloux H, Javre JL, Guerin D, Sampérez S, Jouan P (1988). "[Prognostic value of fetal thymidine kinase measurements in breast cancer]". Comptes Rendus de l'Académie des Sciences, Série III (in French). 306 (3): 89–92. PMID 3126994.

Romain S, Javre JL, Samperez S, Jouan P, Bressac C, Varette I, Brandone H, Martin PM (1990). "[Prognostic value of thymidine kinase in cancer of the breast]". Bulletin du Cancer (in French). 77 (10): 973–83. PMID 2249017.

O'Neill KL, McKelvey VJ, Hoper M, Monteverde H, Odling-Smee GW, Logan H, Abram WP, McKenna PG (1992). "Breast tumour thymidine kinase levels and disease recurrence". Medical Laboratory Sciences. 49 (4): 244–7. PMID 1339926.

Yusa T, Tamiya N, Yamaguchi Y, Takeda T, Ogawa T, Kimura H, Fujimura S (1994). "[A study of thymidine kinase activity in lung cancer tissue]". Nihon KyōBu Shikkan Gakkai Zasshi (in Japanese). 32 (3): 211–5. PMID 8189640.

Look KY, Moore DH, Sutton GP, Prajda N, Abonyi M, Weber G (1997). "Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinoma". Anticancer Research. 17 (4A): 2353–6. PMID 9252646.

Pikner R, Ludvíkova M, Ryska A, Kholova I, Holubec L, Topolcan O, Pecen L, Fínek J (2005). "TPS, thymidine kinase, VEGF and endostatin in cytosol of thyroid tissue samples". Anticancer Research. 25 (3A): 1517–21. PMID 16033053.

Björklund B (1962). "Immunological approaches to the study of cancer". Rontgen Laborator. 15: L21–L28. PMID 13869604.

Huang S, Lin J, Guo N, Zhang M, Yun X, Liu S, Zhou J, He E, Skog S (2011). "Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression". Asian Pacific Journal of Cancer Prevention. 12 (2): 497–505. PMID 21545220.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

Persson L, Gronowitz SJ, Källander CF (1986). "Thymidine kinase in extracts of human brain tumours". Acta Neurochirurgica. 80 (3–4): 123–7. doi:10.1007/bf01812286. PMID 3012969. S2CID 3115996.

Thymidine kinase in clinical chemistry (English Wikipedia)

doi.org

espacenet.com

worldwide.espacenet.com

harvard.edu

ui.adsabs.harvard.edu

murdoch.edu.au

researchrepository.murdoch.edu.au

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

zenodo.org